Valuation Asymchem Laboratories (Tianjin) Co., Ltd. Hong Kong S.E.
Stocks
6821
CNE100004Z06
Pharmaceuticals
|
Delayed
Hong Kong S.E.
03:47:08 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 119.80 HKD | -5.07% |
|
+9.35% | +67.56% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 61,083 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 87.34% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 56,033 | 56,691 | 57,267 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 112.75% | 1.17% | 1.02% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 45x | 36x | 29.4x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.36x | 3.15x | 2.9x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 1.9x | 1.4x | 1.3x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.56x | 6.28x | 5.22x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 6.93x | 5.83x | 4.89x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 26.3x | 21.9x | 17.9x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 35.2x | 28.3x | 22x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -84.4x | 64.5x | 44x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -1.19% | 1.55% | 2.27% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.464 | 1.795 | 2.113 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.84% | 1.03% | 1.21% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.892 | 4.861 | 5.944 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 37.6% | 36.9% | 35.6% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,082 | 9,722 | 11,709 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,134 | 2,590 | 3,192 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,590 | 2,000 | 2,608 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,443 | 1,757 | 2,112 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -5,049 | -4,392 | -3,816 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 175.00 | 175.00 | 175.00 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 34.6x | 12.64x | 25.73x | 0.57% | 1,088B | ||
| 29.02x | - | - | 2.06% | 629B | ||
| 31.76x | 7.4x | 15.37x | 2.76% | 440B | ||
| 20.37x | 4.83x | 11.97x | 2.73% | 359B | ||
| 21.72x | 5.63x | 14.03x | 2.85% | 291B | ||
| 20.24x | 4.18x | 11.87x | 2.1% | 245B | ||
| 26.11x | 6.86x | 12.2x | 2.42% | 225B | ||
| 13.56x | 4.86x | 10.12x | 3.76% | 204B | ||
| -42.19x | 6.04x | 34.06x | 2.43% | 168B | ||
| Average | 17.24x | 6.55x | 16.92x | 2.41% | 405.47B | |
| Weighted average by Cap. | 24.66x | 8.26x | 18.73x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- 6821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















